Literature DB >> 9008323

Chronic treatment with cyclosporine A in New Zealand rabbit: aortic and erectile tissue alterations.

E Ragazzi1, C Meggiato, A Chinellato, G Italiano, F Pagano, A Calabrò.   

Abstract

Transplanted patients frequently present erectile impotence. In order to test any interference by cyclosporine A (CsA), which is commonly used in the post-transplantation management, we investigated the in vitro contractile and relaxant responses of corpus cavernosum and aorta from rabbits chronically treated with CsA. Male New Zealand White rabbits 6 months of age were treated with CsA (25 mg/kg per day s.c.) or solvent (corn oil) for 3 weeks. Descending thoracic aorta and erectile tissue were studied in vitro at the end of treatment. Isometric tension was recorded. In thoracic aorta, noradrenaline (0.1-30 mM) induced a concentration-dependent contraction with no difference between the two groups. Acetylcholine (30 nM-3 mM) produced relaxation (52 +/- 4% at 1 mM) that was significantly reduced in comparison to controls (67 +/- 4%, P < 0.05). ATP (3-10 mM) relaxation was not significantly different (maximal 78 +/- 10% and 62 +/- 12% in CsA-treated and controls). The relaxation produced by sodium nitrite was reduced in CsA-treated rabbits (at 10 mM and 0.1 mM concentrations). In erectile tissue, no significant variation in the response of isolated erectile tissue to the above drugs was observed between CsA-treated and control animals. These data indicate that chronic treatment with CsA in rabbits, despite alteration of the in vitro response of thoracic aorta, does not directly influence the function of penile tissue with relaxants.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9008323     DOI: 10.1007/bf00389787

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  34 in total

1.  Treatment of erectile impotence in renal transplant patients with intracavernosal vasoactive drugs.

Authors:  A Rodriguez Antolin; J M Morales; A Andrés; T Fernández Aparicio; R Díaz González; M Pamplona; E Alvarez
Journal:  Transplant Proc       Date:  1992-02       Impact factor: 1.066

2.  Smooth muscle cell proliferation by conditioned media from cyclosporine-treated endothelial cells: a role of endothelin.

Authors:  T E Bunchman; C A Brookshire
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

3.  Sexual concerns after heart transplantation.

Authors:  J B Tabler; R L Frierson
Journal:  J Heart Transplant       Date:  1990 Jul-Aug

4.  Chronic cyclosporine-induced nephrotoxicity: a rabbit model.

Authors:  J A Thliveris; R W Yatscoff; M J Mihatsch
Journal:  Transplantation       Date:  1994-03-15       Impact factor: 4.939

5.  Endothelial and vascular smooth muscle function after chronic treatment with cyclosporin A.

Authors:  W Auch-Schwelk; C Bossaller; S Götze; J Thelen; E Fleck
Journal:  J Cardiovasc Pharmacol       Date:  1993-03       Impact factor: 3.105

6.  Low-dose cyclosporin nephrotoxicity in the rat.

Authors:  C J Ferguson; C von Ruhland; D J Parry-Jones; D F Griffiths; J R Salaman; J D Williams
Journal:  Nephrol Dial Transplant       Date:  1993       Impact factor: 5.992

7.  Acute cyclosporine-induced renal vasoconstriction is mediated by endothelin-1.

Authors:  I T Bloom; F R Bentley; R N Garrison
Journal:  Surgery       Date:  1993-08       Impact factor: 3.982

8.  Effects of in vivo cyclosporine administration on endothelium-dependent responses in isolated vascular rings.

Authors:  B B Chan; J A Kern; T L Flanagan; I L Kron; C G Tribble
Journal:  Circulation       Date:  1992-11       Impact factor: 29.690

9.  Histological and endocrinological investigations of cyclosporine effects on the rat testis.

Authors:  M Iwasaki; H Fuse; T Katayama
Journal:  Andrologia       Date:  1995 May-Jun       Impact factor: 2.775

Review 10.  Receptor-mediated pathways of endothelium activity in experimental atherosclerosis.

Authors:  A Chinellato; E Ragazzi
Journal:  Pharmacol Res       Date:  1995 Mar-Apr       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.